Viewing nowCombinationAtostazet Tablets 10/10 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication · Combination
Donghwa Pharmaceutical Co., Ltd.

MFDS item code 202101533 · Approved 2021.02.18 · Insurance code 642707030
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication is used as an adjunct to diet to lower levels of total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol in patients with primary hypercholesterolemia, including familial or non-familial hypercholesterolemia and mixed dyslipidemia, and to raise HDL cholesterol levels. It is also administered as an adjunctive treatment for patients with homozygous familial hypercholesterolemia when other lipid-lowering treatments are ineffective or used in combination. This medication helps to reduce the risk of cardiovascular disease, but it must be taken alongside an appropriate diet, and the causes of dyslipidemia must be accurately diagnosed; other treatments should be combined when necessary. During testing, it is important to closely monitor lipid levels to establish an appropriate treatment strategy. This medication is used to manage the risk of atherosclerotic vascular disease associated with hypercholesterolemia.
Administer this medication once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/10mg to 10/80mg once daily. The recommended initial dosage is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), the recommended initial dosage is 10/40mg once daily. After starting treatment or adjusting the dosage, check blood lipid levels at intervals of at least 2 weeks and adjust the dosage accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.
This medication can cause a rare side effect called rhabdomyolysis, which can lead to acute renal failure. Therefore, patients showing symptoms of severe myopathy or those at high risk of renal failure, such as post major surgery, during severe infection, or with hypotension, should temporarily stop or discontinue this medication. Patients with allergies to the components of this drug, severely impaired liver function or persistent unexplained elevated liver enzymes, those with muscle diseases, pregnant or potentially pregnant women, lactating women, patients on certain antiviral medications, and those with genetic issues such as lactose intolerance should not take this medication. Alcoholics, patients with a history of liver disease or severe liver dysfunction, those with poor kidney function or hypothyroidism, patients with a family history of muscle disease, and elderly patients over 70 years old, who are at higher risk of myopathy, should use this medication cautiously. This medication may cause side effects such as myalgia, abdominal pain, and elevation of liver enzymes; severe liver injury, serious skin reactions, and allergic reactions can sometimes occur. If symptoms such as myalgia, muscle weakness, fatigue, or fever occur while taking this medication, the doctor should be informed immediately, and blood tests may be needed to check for muscle damage. If any symptoms of liver dysfunction appear, treatment should be discontinued and follow the doctor's instructions. This medication can interact with other drugs, so if there are currently any medications being taken, the doctor or pharmacist must be informed, especially when co-administering drugs that affect liver metabolism or those that increase the risk of muscle damage. Women of childbearing potential should use adequate contraception to avoid pregnancy while taking this medication, and if pregnancy is confirmed, the medication should be stopped immediately. Lactating women are advised not to take this medication, and safety in pediatric patients has not been established; thus, it is not recommended. Older adults should use this medication with caution due to a higher risk of myopathy, although dosage adjustment is generally not required. In case of overdose, as there is no specific antidote, appropriate treatment and supportive therapy should be provided based on symptoms. Finally, keep this medication out of the reach of children and do not transfer it to another container.
Acute kidney failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, elevated liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyp, duodenal polyp, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenail, thyroid adenoma, lethargy, malaise, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, dyspepsia, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleed, insomnia, nightmares, headache, paresthesia, sensory loss, dysgeusia, memory loss, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, rupture-related complications, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, positive urine white blood cell count, vomiting, abdominal abnormalities, hepatitis, cholestasis, cholestatic jaundice, abnormal liver function test results, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, belching, glossitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, gastric and duodenal ulcers, dysphagia, melena, gingival bleeding, postprandial, bronchitis, rhinitis, pneumonia, dyspnea, asthma, sensory disturbances, dizziness, phototoxic reactions, drowsiness, forgetfulness, abnormal dreams, decreased libido, emotional instability, ataxia, torticollis, facial paralysis, hyperactivity, hypertonia, arthritis, bursitis, tenosynovitis, myasthenia, tendon contracture, elevated CK, increased serum myoglobin, itching, contact dermatitis, dry skin, sweating, acne, eczema, seborrhea, urinary tract infection, increased urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, pigmented urine, hypoglycemia, increased appetite, vascular edema, chest pain, angina, facial swelling, fever, neck stiffness, generalized edema, amblyopia, dry eyes, refractive errors, ocular hemorrhage, hearing loss, glaucoma, pigmentation changes, loss of taste, dysgeusia, leukopenia, decreased testosterone, elevated cholinesterase, increased TSH, increased ACTH, decreased aldosterone, elevated potassium, elevated BUN, cerebral infarction, palpitations, tachycardia, positive urine white blood cell count, anaphylaxis, urticaria, rash, vascular edema, elevated creatine phosphokinase, myopathy, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, cholelithiasis, cholecystitis, drug-induced liver injury, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions with accompanying systemic symptoms, erythema multiforme, fatigue, chest discomfort, edema, weakness, systemic edema, diabetic neuropathy, tremors, upper abdominal pain, gastritis, epigastric discomfort, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, sputum, limb pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
White oblong film-coated tablet
30 tablets/box (10 tablets/PTP packaging (Alu-Alu)x3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication · Combination
Donghwa Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.